BiotechTube
Home/Investors/T. Rowe Price

T. Rowe Price

Biotech Investor · 6 portfolio companies

Portfolio
6
Focus Areas
11
Top Stage
Commercial

Investment Focus

OncologyNeurologyPsychiatryCardiologyRadiologyImmunologyMetabolicCardiovascularGenetics & GenomicsRare DiseasesOphthalmology

Portfolio Companies

CompanyValuation
RefleXion Medical—
Tempus—
Obsidian Therapeutics—
ImmunoGenix—
Vesalius Therapeutics—
GeneEdit Therapeutics—

Frequent Co-Investors

Atlas Venture2 sharedFlagship Pioneering2 sharedGV1 sharedSofinnova Partners1 sharedVertex Ventures HC1 sharedPolaris Partners1 sharedNew Enterprise Associates (NEA)1 sharedKCK Group1 shared